WASHINGTON, DC - The Subcommittee on Oversight and Investigations, chaired by Rep. Tim Murphy (R-PA), has scheduled a hearing for Tuesday, April 29, 2014, at 10 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled “Examining the Growing Problems of Prescription Drug and Heroin Abuse.”
WASHINGTON, DC – The Subcommittee on Environment and the Economy, chaired by Rep. John Shimkus (R-IL), has scheduled a hearing for Tuesday, April 29, 2014, at 10 a.m. in room 2123 of the Rayburn House Office Building. The subcommittee will continue its review of draft legislation, the Chemicals in Commerce Act (CICA). Witnesses to be announced.
Committee Presses FDA for Documents On Trial Lawyers’ Role in Proposed Changes to Generic Drug LabelingApril 22, 2014 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee members today sent a letter to Food and Drug Administration Commissioner Margaret Hamburg, M.D. expressing their concerns regarding the administration’s proposed changes to generic drug labeling. The committee leaders are also concerned with the motivation behind the proposed rule, and who was – and was not – involved in drafting this proposal.
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) today released the following statement in response to the State Department’s announcement that the national interest determination period for the Keystone XL pipeline has been put on hold:
WASHINGTON, DC – Continuing the committee’s oversight of the safety and security of the nation’s electric grid, House Energy and Commerce Committee leaders yesterday wrote to Acting Chairman of the Federal Energy Regulatory Commission (FERC) Cheryl LaFleur seeking information relating to the agency’s management of sensitive security information.
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) issued the following statement regarding the administration’s latest health law data release.